SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-014374
Filing Date
2018-10-11
Accepted
2018-10-11 16:30:32
Documents
19
Period of Report
2018-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 51419
2 ex10-1.htm EX-10.1 13370
3 ex10-2.htm EX-10.2 3023
4 ex10-1_001.jpg GRAPHIC 222053
5 ex10-1_002.jpg GRAPHIC 251606
6 ex10-1_003.jpg GRAPHIC 289065
7 ex10-1_004.jpg GRAPHIC 246747
8 ex10-1_005.jpg GRAPHIC 231285
9 ex10-1_006.jpg GRAPHIC 258920
10 ex10-1_007.jpg GRAPHIC 269773
11 ex10-1_008.jpg GRAPHIC 272481
12 ex10-1_009.jpg GRAPHIC 229776
13 ex10-1_010.jpg GRAPHIC 183513
14 ex10-1_011.jpg GRAPHIC 63759
15 ex10-1_012.jpg GRAPHIC 62917
16 ex10-2_001.jpg GRAPHIC 384110
17 ex10-2_002.jpg GRAPHIC 349194
18 ex10-2_003.jpg GRAPHIC 87810
19 ex99-1.htm EX-99.1 21352
  Complete submission text file 0001493152-18-014374.txt   4778687
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 181118596
SIC: 2835 In Vitro & In Vivo Diagnostic Substances